Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience.
Moniz Dionísio J, Ambrose P, Burke G, Farrugia ME, Garcia-Reitboeck P, Hewamadduma C, Hill M, Howard RS, Jacob S, Kullmann D, Leite MI, Miller J, Pinto A, Pritchard J, Riswick T, Sathasivam S, Thambirajah N, Viegas S, Norwood F, Spillane J.
Moniz Dionísio J, et al. Among authors: garcia reitboeck p.
J Neurol Neurosurg Psychiatry. 2025 Jan 11:jnnp-2024-334086. doi: 10.1136/jnnp-2024-334086. Online ahead of print.
J Neurol Neurosurg Psychiatry. 2025.
PMID: 39798959